Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes
- PMID: 31235907
- DOI: 10.1038/s41593-019-0423-2
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes
Abstract
Parkinson's disease, the most common age-related movement disorder, is a progressive neurodegenerative disease with unclear etiology. Key neuropathological hallmarks are Lewy bodies and Lewy neurites: neuronal inclusions immunopositive for the protein α-synuclein. In-depth ultrastructural analysis of Lewy pathology is crucial to understanding pathogenesis of this disease. Using correlative light and electron microscopy and tomography on postmortem human brain tissue from Parkinson's disease brain donors, we identified α-synuclein immunopositive Lewy pathology and show a crowded environment of membranes therein, including vesicular structures and dysmorphic organelles. Filaments interspersed between the membranes and organelles were identifiable in many but not all α-synuclein inclusions. Crowding of organellar components was confirmed by stimulated emission depletion (STED)-based super-resolution microscopy, and high lipid content within α-synuclein immunopositive inclusions was corroborated by confocal imaging, Fourier-transform coherent anti-Stokes Raman scattering infrared imaging and lipidomics. Applying such correlative high-resolution imaging and biophysical approaches, we discovered an aggregated protein-lipid compartmentalization not previously described in the Parkinsons' disease brain.
Comment in
-
A traffic jam leads to Lewy bodies.Nat Neurosci. 2019 Jul;22(7):1043-1045. doi: 10.1038/s41593-019-0435-y. Nat Neurosci. 2019. PMID: 31235905 No abstract available.
-
Taking a closer look at PD pathology.Nat Rev Neurosci. 2019 Sep;20(9):511. doi: 10.1038/s41583-019-0207-4. Nat Rev Neurosci. 2019. PMID: 31388186 No abstract available.
-
Editorial.Brain. 2019 Nov 1;142(11):3315. doi: 10.1093/brain/awz334. Brain. 2019. PMID: 31665754 No abstract available.
Similar articles
-
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6. Brain. 2005. PMID: 16000336
-
Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.Acta Neuropathol. 2002 Sep;104(3):225-30. doi: 10.1007/s00401-002-0546-4. Epub 2002 May 9. Acta Neuropathol. 2002. PMID: 12172907
-
Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain.Neurosci Lett. 2000 Oct 6;292(2):128-30. doi: 10.1016/s0304-3940(00)01440-3. Neurosci Lett. 2000. PMID: 10998565
-
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.Ann N Y Acad Sci. 2000;920:16-27. doi: 10.1111/j.1749-6632.2000.tb06900.x. Ann N Y Acad Sci. 2000. PMID: 11193145 Review.
-
Formation and development of Lewy pathology: a critical update.J Neurol. 2009 Aug;256 Suppl 3:270-9. doi: 10.1007/s00415-009-5243-y. J Neurol. 2009. PMID: 19711116 Review.
Cited by
-
LRRK2-Related Parkinson's Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis.Front Neurosci. 2020 Jun 4;14:556. doi: 10.3389/fnins.2020.00556. eCollection 2020. Front Neurosci. 2020. PMID: 32581693 Free PMC article. Review.
-
Neurodegenerative Disorder Risk in Krabbe Disease Carriers.Int J Mol Sci. 2022 Nov 4;23(21):13537. doi: 10.3390/ijms232113537. Int J Mol Sci. 2022. PMID: 36362324 Free PMC article.
-
On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson's Disease.Antioxidants (Basel). 2023 Jan 17;12(2):214. doi: 10.3390/antiox12020214. Antioxidants (Basel). 2023. PMID: 36829773 Free PMC article. Review.
-
The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features.Biomedicines. 2023 Feb 13;11(2):541. doi: 10.3390/biomedicines11020541. Biomedicines. 2023. PMID: 36831077 Free PMC article. Review.
-
Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration.Cell Death Dis. 2022 Jul 20;13(7):628. doi: 10.1038/s41419-022-05058-3. Cell Death Dis. 2022. PMID: 35859075 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical